IMMUNOMAGNETIC SEPARATION OF CRYPTOSPORIDIUM-PARVUM FROM SOURCE WATERSAMPLES OF VARIOUS TURBIDITIES

Citation
Z. Bukhari et al., IMMUNOMAGNETIC SEPARATION OF CRYPTOSPORIDIUM-PARVUM FROM SOURCE WATERSAMPLES OF VARIOUS TURBIDITIES, Applied and environmental microbiology (Print), 64(11), 1998, pp. 4495-4499
Citations number
15
Categorie Soggetti
Microbiology,"Biothechnology & Applied Migrobiology
ISSN journal
00992240
Volume
64
Issue
11
Year of publication
1998
Pages
4495 - 4499
Database
ISI
SICI code
0099-2240(1998)64:11<4495:ISOCFS>2.0.ZU;2-I
Abstract
Immunomagnetic separation (IMS) procedures which specifically capture Cryptosporidium oocysts and have the potential to isolate oocysts from debris have become commercially available. We compared two IMS kits ( kit DB [Dynabeads anti-Cryptosporidium; product no. 730.01; Dynal A.S. , Oslo, Norway] and kit IC1 [Crypto Scan IMS; product no. R10; Clearwa ter Diagnostics Company, LLC, Portland, Maine]) and a modification of kit IC1 (kit IC2 [Crypto Scan IMS; product no. R10; Clearwater Diagnos tics Company, LLC]) at three turbidity levels (50, 500, and 5,000 neph elometric turbidity units [ntu]) by using water matrices obtained from different geographical locations. In deionized water, kit DB yielded recoveries between 68 and 83%, whereas the recoveries obtained with ki ts IC1 and IC2 were more variable and ranged from 0.2 to 74.5%. In wat er matrices with turbidity levels up to 500 ntu, the oocyst recoveries were more variable with kit DB; however, the recoveries were similar to those obtained in deionized water. In contrast, there were notable reductions in oocyst recoveries in the turbid matrices with kits IC1 a nd IC2, and the highest recovery (8.3%) was obtained with a 50-ntu sam ple. An examination of the effects of age on oocyst recovery with kit DB revealed that oocysts up to 16 weeks old yielded recoveries similar to the recoveries observed,vith fresh oocysts, These data indicate th at all IMS kits do not perform equally well, and it is important to co nduct in-house quality assurance work before a commercially available IMS kit is selected to replace flotation procedures for recovery of Cr yptosporidium oocysts.